Avisa Diagnostics Inc.
FOGCF
$0.00
$0.000.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, August 27, 2021
Period Date
Wednesday, June 30, 2021
Next Filing
(est)
Price History
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
Address
Royal Centre
Suite 2050 - 1055 West Georgia Street
PO Box 11121 Vancouver, BC V6E 3P3
Suite 2050 - 1055 West Georgia Street
PO Box 11121 Vancouver, BC V6E 3P3
Country
Year Founded
--
Business Description
Sector
Industry
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid...
more
